The Effect of Gelesis100 on the Pharmacokinetics of Metformin

Bioequivalence Study of Metformin Hydrochloride Tablets 1000 mg Tablets of Dr. Reddy's Laboratories Limited Under Fasting Condition

NCT01160042 ·Status: COMPLETED ·Phase: PHASE1

A Relative Bioavailability Study of Metformin HCL Tablets, 1000 mg Under Fasting Conditions

NCT00865033 ·Status: COMPLETED ·Phase: PHASE1

BE STUDY OF METFORMIN GSK 1000mg

NCT01710553 ·Status: COMPLETED ·Phase: PHASE2

A Comparitive Bioavailability Study of Metformin Hydrochloride Liquid 500mg/ 5 mL Under Fasting Conditions and After Low and High Fat Meal

NCT00778349 ·Status: COMPLETED ·Phase: NA

Relative Bioavailability of Multiple Oral Doses of BI 187004 and Metformin After Co-administration Compared to Multiple Oral Doses of BI 187004 Alone and Metformin Alone in Healthy Male Subjects

NCT02109679 ·Status: COMPLETED ·Phase: PHASE1

Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Extended Release Metformin and Extended Release Glimepiride in Health Volunteers

NCT01725672 ·Status: TERMINATED ·Phase: PHASE1

BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 2000mg in Comparison to Each Component Administered Alone

NCT02670018 ·Status: UNKNOWN ·Phase: PHASE1

Bioequivalence Study of Metformin Component of Canagliflozin and Metformin Fixed Dose Combination Immediate Release (IR) Tablet Comparing With Metformin IR Tablet Co-administered With Canagliflozin Tablet in Healthy Fed and Fasted Participants

NCT02220218 ·Status: COMPLETED ·Phase: PHASE1

Relative Bioavailability of a Linagliptin+Metformin Fixed Dose Combination Tablet Administered With and Without Food to Healthy Male and Female Subjects

NCT02223026 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalence Study of Metformin Hydrochloride Liquid 500mg/ 5 mL Under Fed Conditions

NCT00780013 ·Status: COMPLETED ·Phase: NA

Drug-Drug Interaction Study to Evaluate the Effect of PF-06865571 on Metformin Pharmacokinetics

NCT03593707 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalence Study of Two Strengths of Two Different Metformin Tablets Administered to Healthy Male and Female Subjects

NCT02183571 ·Status: COMPLETED ·Phase: PHASE1

BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 1000mg in Comparison to Each Component Administered Alone

NCT01662674 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalence Study of Metformin Hydrochloride Tablets 1000 mg Tablets of Dr. Reddy's Laboratories Limited Under Fed Condition

NCT01160068 ·Status: COMPLETED ·Phase: PHASE1

BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 1000mg in Comparison to Each Component Administered Alone.

NCT02056600 ·Status: COMPLETED ·Phase: PHASE1

Efficacy Study of Metformin Glycinate on Postprandial Lipemia

NCT02064881 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

BE Study of the Combinations of Gemigliptin/Metformin HCl Extended Release 50/1000mg(25/500mg x 2 Tablets) in Comparison to Each Component Administered Alone

NCT03355014 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Clinical Study to Evaluate the Effect of GZR18 Injection on the Pharmacokinetics of Oral Metformin Hydrochloride Tablets in Overweight/Obese Subjects

NCT06670209 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Food-Effect Bioavailability Study of FDC(Gemigliptin/Metformin HCl Sustained Release) 50/1000mg(25/500mg x 2tablets)

NCT01747083 ·Status: COMPLETED ·Phase: PHASE1

Clinical Trial to Evaluate Safety and pK Profile of Metformin Glycinate in Healthy Volunteers

NCT01560481 ·Status: COMPLETED ·Phase: PHASE1

OXEMET™ 1000 mg Coated Tablets (Metformin Hydrochloride) Bioequivalence Study. OXEMET (TM) is a Trademark of the GlaxoSmithKline Group of Companies. GLAFORNIL(TM) is a Trademark of Merck.

NCT01842620 ·Status: COMPLETED ·Phase: PHASE4

A Open-label, Single-dose, 2-Sequence, 2-Period, Crossover Study to Assess Safety and Pharmacokinetics of a Nateglinide/Metformin HCl Combined Tablet Compared With a Nateglinide 120 mg Tablet and Metformin HCl 500 mg Tablet Under Fasting Conditions in Healthy Male Subjects

NCT02088918 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalence Study of Metformin Hydrochloride 1000mg Tablets Under Fasting Conditions

NCT00778427 ·Status: COMPLETED ·Phase: NA

Effect of Metformin, a Drug Used to Treat Diabetes, vs Placebo

NCT05949008 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Relative Bioavailability of Two Different Batches of a Linagliptin / Metformin Combination Tablet in Healthy Volunteers

NCT01216397 ·Status: COMPLETED ·Phase: PHASE1